Predictive testing for BRCA1 and 2 mutations: A male contribution

Annals of Oncology

Volumn 14, Issue 4, 2003, Pages 549-553

  Daly, P A ^a   Nolan, C ^a   Green, A ^b   Ormiston, W ^a   Cody, N ^b   McDevitt, T ^b   O'hIei, B ^b   Byrne, D ^a   McDermott, E ^b   Carney, D N ^b   O'Higgins, N ^b   Barton, D E ^b  

^a ST JAMES S HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

BRCA1; BRCA2; Cancer genetics; Predictive testing in men

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER GENETICS; CANCER RISK; CLINICAL ARTICLE; DNA DETERMINATION; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; INFORMED CONSENT; MALE; MENTAL STRESS; MOTIVATION; MUTATIONAL ANALYSIS; ONCOGENE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGENY; PROSTATE CANCER; TUMOR SUPPRESSOR GENE; FAMILY HEALTH; FEMALE; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATIENT CARE PLANNING; PEDIGREE; PREDICTION AND FORECASTING; PROGNOSIS;

ADULT; AGED; BREAST NEOPLASMS, MALE; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; MALE; MIDDLE AGED; PATIENT CARE PLANNING; PEDIGREE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STRESS, PSYCHOLOGICAL;

EID: 0038495624     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg164     Document Type: Article

References (26)

1. Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266:66-71.
2. Wooster R, Bignell G, Lancaster J et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378: 789-792.
3. [Erratum, Nature 1996; 379: 749].
4. Hubbard R, Lewontin RC. Pitfalls of genetic testing. N Engl J Med 1996; 334: 1192-1194.
5. Burke W, Daly M, Garber J et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA1 and BRCA2. J Am Med Assoc 1997; 277: 997-1003.
6. Haber DA. Breast cancer in carriers of BRCA1 and BRCA2 mutations: tackling a molecular and clinical conundrum. J Clin Oncol 1999; 17: 3367-3370.
7. Peshkin BN, De Marco TA, Brogan BM et al. BRCA1/2 testing: complex themes in result interpretation. J Clin Oncol 2001; 19: 2555-2565.
8. Meijers-Heijboer H, Van Geel B, Van Putten WLJ et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2001; 345: 159-164.
9. Van Roosmalen MS, Verhoef LCG, Stalmeier PFM et al. Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy. J Clin Oncol 2002; 20: 2092-2100.
10. Kauff ND, Satagopan JM, Robson ME et al. Risk-reducing salpingo-oophorectomy in woman with a BRCA1 and BRCA2 mutation. N Engl J Med 2002; 346: 1609-1615.
11. Rebbeck TR, Lynch HT, Neuhausen SL et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002; 346: 1616-1622.
12. Narod SA, Brunet J-S, Ghadirian P et al. Tamoxifen and risk of contra-lateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet 2000; 356: 1876-1881.
13. Frank TS, Deffenbaugh AM, Reid JE et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10000 individuals. J Clin Oncol 2002; 20: 1480-1490.
14. Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 1999; 91: 1310-1316.
15. Ford D, Easton DF, Stratton M et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998; 62: 676-689.
16. Struewing JP, Hartge P, Wacholder S et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401-1408.
17. Easton DF, Steele P, Ormiston W et al. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q 12-13. Am J Hum Genet 1997; 61: 120-128.
18. McAllister M, Evans G, Ormiston W et al. Men in breast cancer families: a preliminary qualitative study of awareness and experience. J Med Genet 1998; 35: 739-744.
19. Lodder L, Frets PG, Trijsburg R et al. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing. Eur J Hum Genet 2001; 9: 492-500.
20. Liede A, Metcalfe K, Hanna D et al. Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. Am J Hum Genet 2000; 67: 1494-1504.
21. Hogervorst FBL, Cornelis RS, Bout M et al. Rapid detection of BRCA1 mutations by the protein truncation test. Nature Genet 1995; 10: 208-212.
22. Lerman C, Seay J, Balshem A, Audrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 1995; 57: 385-392.
23. Bleiker EMA, Aaronson NK, Menko FH et al. Genetic counseling for hereditary cancer: a pilot study on experiences of patients and family members. Patient Educ Couns 1997; 32: 107-116.
24. Lynch HT, Lemon SJ, Durham C et al. A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer 1997; 79: 2219-2228.
25. Dorval M, Farkis P, Schneider KA et al. Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs. J Clin Oncol 2000; 18: 2135-2142.
26. Lerman C, Hughes C, Lemon S J et al. What you don't know can hurt you: adverse psychological effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol 1998; 16: 1650-1654.